胆固醇生物合成支持缺乏脂肪酸合酶的小鼠和人类肝细胞癌病变的生长
研究在小鼠肝细胞癌模型中探讨脂肪酸合酶介导的从头脂肪酸合成的作用,发现敲除Fasn可延迟但未阻止肿瘤发生,肿瘤中胆固醇合成基因上调;抑制Srebp2可完全预防Fasn敲除小鼠的肝癌发生,同时抑制FASN和HMGCR对肝癌细胞生长高度不利。
要点
- 敲除Fasn显著延迟sgPten/c-Met驱动的小鼠肝癌发生,但肿瘤最终仍出现。
- Fasn缺失的肝癌中胆固醇合成基因上调,Srebp2核转位激活触发胆固醇生成。
- 显性负性Srebp2阻断胆固醇合成可完全预防Fasn敲除小鼠的肝癌发生。
核心结论
- 研究揭示了异常脂肪生成与胆固醇生物合成通路在肝癌发生中的新功能交叉对话,同时抑制这两条通路可能成为肝细胞癌的治疗选择。
研究设计与样本
- 使用肝脏特异性Fasn敲除小鼠在Pten缺失和c-Met过表达(sgPten/c-Met)诱导的鼠肝癌模型中研究Fasn介导的从头脂肪酸合成的作用。
- 对野生型和Fasn敲除小鼠的sgPten/c-Met肝癌进行表达芯片和脂质组学分析。
- 使用人肝癌细胞系进行体外研究。
主要发现
- 敲除Fasn显著延迟sgPten/c-Met驱动的小鼠肝癌发生,但Fasn敲除小鼠最终仍出现肝癌。
- 比较基因组和脂质组学分析显示,这些小鼠肝癌中胆固醇生物合成相关基因上调,甘油三酯水平降低,胆固醇酯增加。
- 机制上,Fasn缺失促进甾醇调节元件结合蛋白2(Srebp2)的核转位和激活,从而触发胆固醇生成。
- 通过显性负性Srebp2(dnSrebp2)阻断胆固醇合成完全预防了Fasn敲除小鼠中sgPten/c-Met驱动的肝癌发生。
- 在人肝癌细胞系中,沉默FASN导致SREBP2激活增加和羟甲基戊二酰辅酶A(HMG-CoA)还原酶(HMGCR)表达增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Increased de novo fatty acid (FA) synthesis and cholesterol biosynthesis have been independently described in many tumour types, including hepatocellular carcinoma (HCC). DESIGN: We investigated the functional contribution of fatty acid synthase (Fasn)-mediated de novo FA synthesis in a murine HCC model induced by loss of Pten and overexpression of c-Met (sgPten/c-Met) using liver-specific Fasn knockout mice. Expression arrays and lipidomic analysis were performed to characterise the global gene expression and lipid profiles, respectively, of sgPten/c-Met HCC from wild-type and Fasn knockout mice. Human HCC cell lines were used for in vitro studies. RESULTS: Ablation of Fasn significantly delayed sgPten/c-Met-driven hepatocarcinogenesis in mice. However, eventually, HCC emerged in Fasn knockout mice. Comparative genomic and lipidomic analyses revealed the upregulation of genes involved in cholesterol biosynthesis, as well as decreased triglyceride levels and increased cholesterol esters, in HCC from these mice. Mechanistically, loss of Fasn promoted nuclear localisation and activation of sterol regulatory element binding protein 2 (Srebp2), which triggered cholesterogenesis. Blocking cholesterol synthesis via the dominant negative form of Srebp2 (dnSrebp2) completely prevented sgPten/c-Met-driven hepatocarcinogenesis in Fasn knockout mice. Similarly, silencing of FASN resulted in increased SREBP2 activation and hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase (HMGCR) expression in human HCC cell lines. Concomitant inhibition of FASN-mediated FA synthesis and HMGCR-driven cholesterol production was highly detrimental for HCC cell growth in culture. CONCLUSION: Our study uncovers a novel functional crosstalk between aberrant lipogenesis and cholesterol biosynthesis pathways in hepatocarcinogenesis, whose concomitant inhibition might represent a therapeutic option for HCC.
引用
- Che L, Chi W, Qiao Y, et al. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans. Gut. 2019. PMID: 30954949. doi:10.1136/gutjnl-2018-317581
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。